AMPK upregulates KCa2.3 channels and ameliorates endothelial dysfunction in diet-induced obese mice

Biochem Pharmacol. 2021 Jan:183:114337. doi: 10.1016/j.bcp.2020.114337. Epub 2020 Nov 11.

Abstract

The opening of endothelial small-conductance calcium-activated potassium channels (KCa2.3) is essential for endothelium-dependent hyperpolarization (EDH), which predominantly occurs in small resistance arteries. Adenosine monophosphate-activated protein kinase (AMPK), an important metabolic regulator, has been implicated in regulating endothelial nitric oxide synthase activity. However, it was unclear whether AMPK regulated endothelial KCa2.3-mediated EDH-type vasodilation. Using bioinformatics analysis and myograph system, we investigated the regulation by AMPK of KCa2.3 in human umbilical vein endothelial cells (HUVECs) or mouse second-order mesenteric resistance arteries. In HUVECs, AMPK activation either by activators (AICAR, A769662 and MK-8722) or expression of the constitutively active form of AMPK significantly upregulated KCa2.3 expression. Such effects were abolished by AMPK inhibitor (compound C) or AMPK α1-/α2-siRNA, extracellular-signal-regulated-kinase 5 (ERK5) inhibitor (ERK5-IN-1), and specific siRNA to myocyte-enhancer factor 2 (MEF2) or krüppel-like factor 2/4 (KLF2/4). KCa2.3 expression was significantly reduced in mesenteric resistance arteries in AMPKα2 knockout mice when compared with littermate control mice. Furthermore, in high-fat diet fed mice, 2-week treatment with AICAR restored endothelial KCa2.3 expression in mesenteric resistance arteries with improved endothelial dysfunction. Our results demonstrate that activation of AMPK upregulates KCa2.3 channel expression through the ERK5-MEF2-KLF2/4 signaling pathway in vascular endothelium, which contributes to benefits through KCa2.3-mediated EDH-type vasodilation in mesenteric resistance arteries.

Keywords: Adenosine monophosphate-activated protein kinase; Endothelial cells; Mesenteric resistance arteries; Small-conductance Ca(2+)-activated potassium channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / biosynthesis*
  • Animals
  • Diet, High-Fat / adverse effects*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Indoles / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Obesity / etiology
  • Obesity / metabolism*
  • Oximes / pharmacology
  • RNA, Small Interfering / pharmacology
  • Small-Conductance Calcium-Activated Potassium Channels / antagonists & inhibitors
  • Small-Conductance Calcium-Activated Potassium Channels / biosynthesis*
  • Up-Regulation / drug effects
  • Up-Regulation / physiology*

Substances

  • 6,7-dichloro-1H-indole-2,3-dione 3-oxime
  • Indoles
  • Kcnn3 protein, mouse
  • Oximes
  • RNA, Small Interfering
  • Small-Conductance Calcium-Activated Potassium Channels
  • AMPK alpha2 subunit, mouse
  • AMP-Activated Protein Kinases